Literature DB >> 27182161

Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer.

Fang Peng1, Ying Huang1, Mao-Yu Li1, Guo-Qing Li1, Hui-Chao Huang1, Rui Guan1, Zhu-Chu Chen1, Song-Ping Liang1, Yong-Heng Chen1.   

Abstract

AIM: To discover novel biomarkers for early diagnosis, prognosis or treatment of human colorectal cancer.
METHODS: iTRAQ 2D LC-MS/MS analysis was used to identify differentially expressed proteins (DEPs) in the human colonic epithelial carcinogenic process using laser capture microdissection-purified colonic epithelial cells from normal colon, adenoma, carcinoma in situ and invasive carcinoma tissues.
RESULTS: A total of 326 DEPs were identified, and four DEPs (DMBT1, S100A9, Galectin-10, and S100A8) with progressive alteration in the carcinogenic process were further validated by immunohistochemistry. The DEPs were involved in multiple biological processes including cell cycle, cell adhesion, translation, mRNA processing, and protein synthesis. Some of the DEPs involved in cellular process such as "translation" and "mRNA splicing" were progressively up-regulated, while some DEPs involved in other processes such as "metabolism" and "cell response to stress" was progressively down-regulated. Other proteins with up- or down-regulation at certain stages of carcinogenesis may play various roles at different stages of the colorectal carcinogenic process.
CONCLUSION: These findings give insights into our understanding of the mechanisms of colorectal carcinogenesis and provide clues for further investigation of carcinogenesis and identification of biomarkers.

Entities:  

Keywords:  Biomarker; Carcinogenesis; Colorectal Cancer; Proteome

Mesh:

Substances:

Year:  2016        PMID: 27182161      PMCID: PMC4858633          DOI: 10.3748/wjg.v22.i18.4515

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  56 in total

1.  Laser-capture microdissection.

Authors:  Virginia Espina; Julia D Wulfkuhle; Valerie S Calvert; Amy VanMeter; Weidong Zhou; George Coukos; David H Geho; Emanuel F Petricoin; Lance A Liotta
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 2.  Cancer and the complement cascade.

Authors:  Martin J Rutkowski; Michael E Sughrue; Ari J Kane; Steven A Mills; Andrew T Parsa
Journal:  Mol Cancer Res       Date:  2010-09-24       Impact factor: 5.852

3.  Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF.

Authors:  Wells W Wu; Guanghui Wang; Seung Joon Baek; Rong-Fong Shen
Journal:  J Proteome Res       Date:  2006-03       Impact factor: 4.466

Review 4.  Cancer metabolism: what we can learn from proteomic analysis by mass spectrometry.

Authors:  Weidong Zhou; Lance A Liotta; Emanuel F Petricoin
Journal:  Cancer Genomics Proteomics       Date:  2012-11       Impact factor: 4.069

5.  A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.

Authors:  Damien Besson; Aude-Hélène Pavageau; Isabelle Valo; Anthony Bourreau; Audrey Bélanger; Caroline Eymerit-Morin; Alice Moulière; Agnès Chassevent; Michelle Boisdron-Celle; Alain Morel; Jerôme Solassol; Mario Campone; Erick Gamelin; Benjamin Barré; Olivier Coqueret; Catherine Guette
Journal:  Mol Cell Proteomics       Date:  2011-10-10       Impact factor: 5.911

6.  Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells.

Authors:  Weidong Zhou; Michela Capello; Claudia Fredolini; Leda Racanicchi; Lorenzo Piemonti; Lance A Liotta; Francesco Novelli; Emanuel F Petricoin
Journal:  J Proteome Res       Date:  2011-11-17       Impact factor: 4.466

7.  Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.

Authors:  W Wu; B L Kemp; M L Proctor; A F Gazdar; J D Minna; W K Hong; L Mao
Journal:  Cancer Res       Date:  1999-04-15       Impact factor: 12.701

8.  Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma.

Authors:  Meixiang Li; Cui Li; Danjuan Li; Yuanjie Xie; Jinfeng Shi; Guoqing Li; Yongjun Guan; Maoyu Li; Pengfei Zhang; Fang Peng; Zhiqiang Xiao; Zhuchu Chen
Journal:  Clin Exp Metastasis       Date:  2012-06-17       Impact factor: 5.150

9.  Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-based quantitative proteomics.

Authors:  Wan-Sheng Wang; Xiao-Hui Liu; Ling-Xiao Liu; Da-Yong Jin; Peng-Yuan Yang; Xiao-Lin Wang
Journal:  J Proteomics       Date:  2013-04-06       Impact factor: 4.044

10.  A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis.

Authors:  Nathan E Reticker-Flynn; David F Braga Malta; Monte M Winslow; John M Lamar; Mary J Xu; Gregory H Underhill; Richard O Hynes; Tyler E Jacks; Sangeeta N Bhatia
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

View more
  8 in total

1.  Overexpression of galectin2 (LGALS2) predicts a better prognosis in human breast cancer.

Authors:  Mandika Chetry; Adheesh Bhandari; Ruiling Feng; Xinming Song; Pintian Wang; Jing Lin
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 4.060

Review 2.  Proteomic Research on the Antitumor Properties of Medicinal Mushrooms.

Authors:  Boris Jakopovic; Nada Oršolić; Ivan Jakopovich
Journal:  Molecules       Date:  2021-11-05       Impact factor: 4.411

Review 3.  Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?

Authors:  Yuanwei Shi; Danting Tang; Xiaoqi Li; Xiaoli Xie; Yufu Ye; Lijuan Wang
Journal:  Front Oncol       Date:  2022-05-23       Impact factor: 5.738

4.  SMYD2 facilitates cancer cell malignancy and xenograft tumor development through ERBB2-mediated FUT4 expression in colon cancer.

Authors:  Yanzong Lai; Yang Yang
Journal:  Mol Cell Biochem       Date:  2020-04-27       Impact factor: 3.842

Review 5.  Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.

Authors:  Kamil Wdowiak; Tomasz Francuz; Enrique Gallego-Colon; Natalia Ruiz-Agamez; Marcin Kubeczko; Iga Grochoła; Jerzy Wojnar
Journal:  Int J Mol Sci       Date:  2018-01-10       Impact factor: 5.923

6.  Chemical composition and the potential for proteomic transformation in cancer, hypoxia, and hyperosmotic stress.

Authors:  Jeffrey M Dick
Journal:  PeerJ       Date:  2017-06-06       Impact factor: 2.984

7.  Squalene synthase predicts poor prognosis in stage I-III colon adenocarcinoma and synergizes squalene epoxidase to promote tumor progression.

Authors:  Huihong Jiang; Erjiang Tang; Ying Chen; Hailong Liu; Yun Zhao; Moubin Lin; Luwei He
Journal:  Cancer Sci       Date:  2022-01-06       Impact factor: 6.716

8.  Proteomic indicators of oxidation and hydration state in colorectal cancer.

Authors:  Jeffrey M Dick
Journal:  PeerJ       Date:  2016-07-20       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.